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1. Introduction 
Endovascular treatment of intracranial aneurysm has been increasingly performed worldwide. 
The recent publication of a multiple center randomized trial showing improved safety and 
clinical outcome of patients treated with endovascular methods as compared with open 
clipping is encouraging to endovascular neurosurgeons and accelerates this trend. 1 Stent-
assisted coil embolization, which is earliest reported by Higashida in 1997 2 and now widely 
accepted, has expanded the treatment possibilities. It allows for adequate coil placement, 
prevents coil protrusion into the parent vessel, and also helps prevent aneurysm 
recanalization. In the last decade, the development of intracranial stents has increased the 
options for the treatment of wide-necked aneurysms. Successful experiences of the stent-
assisted coiling have been reported by many teams in endovascular neurosurgery centers 
throughout the world. However, most of the reported complications involved a limited 
number of patients and varied among reports.3,4 There has been no systematic report of a 
relatively larger number of patients treated at a single institution, to provide an overview of 
these complications. The purposes of this article are to systematically document and analyze 
the periprocedural and follow-up complications of stent-assisted coiling of cerebral aneurysms 
at our institution and to tentatively answer the following question: is the incidence of 
complications with stent-assisted coiling acceptable, compared with the benefits?  
2. Patients and methods 
2.1. Patient population 
Between Jul 2003 and Dec 2009, 232 consecutive patients with 239 wide-neck aneurysms 
underwent stent-assisted coil embolization at our institution. Therapeutic alternatives were 
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discussed between neurosurgical and neurointerventional teams. Informed consent from the 
patients and institutional review board approval was obtained. The medical records, 
radiographic studies and endovascular procedure reports were reviewed. Patient and 
aneurysm characteristics are summarized in table 1. 
No. of patients 232
Age (y)
Mean 55.1
Range 18-81
Gender
Female 142
Male 90
Ruptured aneurysms (%) 129 (54.0)
Hunt and Hess grade
I 39
II 46
III 34
IV 7
V 3
Unruptured aneurysms (%) 110 (46.0)
Headache 35
Previous SAH 29
Incidental 22
CN paisy 13
TIA 11
Aneurysm location (%)
Anterior Circulation 195 (81.6)
   PcomA 49
   AcomA 12
   Paraclinoid ICA 41
   Cavernous ICA 20
   Ophthalmic 37
   ICA bifurcation 14
   AchoA 17
   A1 segment of ACA 5
Posterior Circulation 44 (18.4)
   BA 18
   VA 12
   VB junction 9
   PICA 5
Aneurysm size (%)
   Small 164(68.6)
   Large 43(18.0)
   Giant 32(13.4)
Neck size (mm)
   Mean 5.9
   Range 2-24
Note: SAH, subarachnoid hemorrhage; TIA, transient ischemic attack; PcomA, posterior communicating artery; 
AcomA, anterior communicating artery; Acho: anterior choroidal artery; ICA, internal carotid artery; ACA , anterior 
cerebral artery; BA, basilar artery; VA, vertebral artery; VB, vertebrobasilar; PICA, posterior inferior cerebellar artery, 
small, <10 mm; large, >10-25 mm; giant, >25 mm. 
Table 1. Patient and aneurysm characteristics 
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2.2. Treatment procedures 
All procedures were performed under general anesthesia. Patients having unruptured 
aneurysms were premedicated with antiplatelet therapy consisting of aspirin 300 mg and 
clopidogrel 75 mg for 3 days before the procedure. Patients with SAH were loaded with 
aspirin 300 mg and clopidogrel 225 mg via nasogastric tube after general anesthesia. All 
patients received systemic heparinization to raise the activated clotting time (ACT) at about 
300 seconds and continuous intravenous infusion of Nimodipine, 2mg/hour to prevent 
vasospasm during the procedure. In patients with ruptured aneurysms, heparinization 
started before puncture, and in patients who presented with acute SAH, heparinization 
started after aneurysm catheterization. A full three- or four-vessel cerebral angiogram was 
performed to permit a complete evaluation of the aneurysm, measure the aneurysm neck, 
width, and height, and measure the parent artery proximal and distal to the aneurysm. A 6F 
or 8F sheath was introduced in the right femoral artery following a standard Seldinger 
puncture. A 6F or 8F Envoy guiding catheter (Johnson & Johnson) was then guided into 
either the cervical internal carotid or vertebral artery, depending on the location of the 
aneurysm. The microcatheters were Prowler series (Johnson & Johnson), Excelsior SL-10, or 
Excelsior 1018 (Boston Scientific/Target Therapeutics). In all cases, embolization was 
completed by packing the aneurysm sac with a variety of commercially available coils. After 
the procedure, the patient was moved to the neurosurgery intensive care unit for 
monitoring and received low-molecular weight heparin calcium 4000IU/12h for the next 48 
hours. Clopidogrel 75 mg each day was orally taken for an additional 30 days, and aspirin 
100 mg for 6 months. 
2.3. Stenting strategies 
Stent deployment was successful in 237 of 239 aneurysms, and failed in two aneurysms. 
Strategies used regarding the sequence of stenting and coiling in 237 treated aneurysms 
were the following: 
1. Stents were delivered before coiling in 205 of 237 aneurysms (86.5%). 
a. Stenting before coiling in the same session in 191 aneurysms (80.6%). In 67 of 191 
aneurysms, the sequential technique was used, by which the microcatheter was 
introduced into the sac through the struts of the stent. In 93 of 191 aneurysms, the 
jailing technique was used, by which the coiling catheter was “jailed” between the 
vessel wall and the stent. Other 31 of 191 aneurysms were treated using the semi-
deployment technique. It consisted of the delivery microcatheter into the aneurysm sac 
and navigating a self-expandable stent into the parent vessel, and subsequently 
partially deploying (approximate 50%-60% of its opening) the stent, which covered the 
distal part of the aneurysm to narrow the neck and leaves room to modify the coil 
delivery microcatheter position during embolization. After a homogeneous coil framing 
or complete embolization is achieved, the stent was fully deployed. If necessary, coiling 
could be continued using traditional jailing technique to obtain circulatory exclusion of 
the lesion. A illustrated case of the whole semi-deployment technique is shown in 
Figure 1. 
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Figure 1. Three dimensional reconstruction (A) of the right ICA in anteroposterior view demonstrated a 
posterior communicating artery aneurysm. The Neuroform stent delivery system was brought up over 
the exchange microguidewire to cross the aneurysm neck. The stent was partly deployed to narrow the 
aneurysm neck after aneurysm catheterization (B). Homogeneous coil framing was achieved without 
coil prolapse by the limitation of the partially-deployed stent. (C). After several coils were placed, the 
stent was fully deployed and coiling continued using traditional jailing technique (D). Postprocedure 
angiogram (E) revealed complete occlusion. 13 months follow-up right common carotd artery 
angiogram (F) revealed high-grade stenosis within the stented segments of right ICA. Collateralisation 
was seen over the anterior communicating artery from the left side (G). Superselective angiogram (H) 
demonstrated that right ICA was not completely occluded. Then, balloon angioplasty of the right ICA 
was performed (I). Postangioplasty control angiography demonstrated substantial improvement in the 
caliber, but flow to right cerebral anterior artery was still delayed (J). 
b. Stenting before coiling in a second session in 14 aneurysms (5.9%). The main reason for 
using this option was the difficulties of accessing the aneurysm for coiling after initial 
stent placement, especially when the parent artery was tortuous, or the aneurysm was 
small. The coiling procedure was usually performed from 1 to 2 months after the 
stenting procedure. 
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2. Stents were delivered after coiling in 31 of 237 aneurysms (13.1%). 
a. Stenting after coiling with balloon remodeling technique in 24 aneurysms. The choice of 
this option was to decrease the risk of thromboembolism complications in some 
partially thrombosed aneurysms. 
b. Bail-out stenting in 7 aneurysms. In these cases, the deployment of the stent was not 
planned in advance. Trapping of an extruded coil or coil mass by means of stent 
placement could prevent parent vessel closure and obviate the need for coil removal. 
3. Stent was delivered alone in one aneurysm (0.4%). A 38-year-old woman with a basilar 
aneurysm was planned to treat with sequential technique. Because trans-stent 
aneurysm catheterization was difficult and caused stent movement, coil embolization 
was postponed to a second session. Fortunately, intraaneurysmal spontaneous 
thrombosis was noted by angiography 3 months later, and coiling was no more an 
option for her. Complete occlusion was observed at 1-year follow-up angiography 
(Figure 2).  
 
Figure 2. Angiography demonstrated a basilar trunk aneurysm in a 38-year-old woman with SAH (A 
B). A Neuroform stent (4.5 × 20 mm) was deployed across the aneurysm neck, and coil embolization 
was postponed to a second session due to difficulty in trans-stent aneurysm catheterization (C). One-
year follow-up angiography demonstrated complete occlusion (D E). 
2.4. Data collection 
All patients underwent CT scanning within 6 hours after the procedure. During the hospital 
stays, physicians performed neurological examinations of the patients once each day. After 
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discharge, clinical follow-up data were collected by clinic visitation, follow-up angiography, 
or telephone interview. Clinical outcome was graded according to modified Rankin score 
(mRS), as follows: excellent (mRS 0-1), good (mRS 2), poor (mRS 3-4) and death (mRS 5). For 
each patient, 6 months, 1 year, 3 year and 5 year follow-up angiogram were recommended. 
The pre-embolization, post-embolization and follow-up (if possible) angiograms were 
reviewed and compared by 2 senior endovascular neurosurgeons not involved in the 
procedure for initial and follow-up occlusion grade, which was classified as class 1: 
complete occlusion (no contrast filling the aneurysmal sac); class 2: neck remnant (residual 
contrast filling the aneurysmal neck); class 3: residual flow (residual contrast filling the 
aneurysmal body). 5 Recanalization was defined as more than 10 % increase in contrast 
filling of the aneurysm; less than 10 % increased filling was defined as unchanged. 6 
Angiographic results and clinical outcome were evaluated. Cases with complications were 
analyzed, including radiological findings, clinical presentations, management experience 
and clinical sequelae. 
2.5. Statistical analysis 
SPSS 11.0 software (SPSS, Inc, Chicago, IL) was used for statistical analysis. A chi-square test 
was used to compare the incidences of intraprocedural rupture and thromboembolic 
complications between ruptured unruptured aneurysms and to compare the incidences of 
complete occlusion rate between different stenting strategies. 
3. Results 
3.1. Angiographic results 
Immediate angiographic results of the 236 aneurysms treated with stent-assited coiling are 
summarized in Table 2. 
  class 1 class 2 class 3 
Overall 236 162 45 29 
Small 162 128 21 13 
Large 41 22 11 8 
Giant 33 12 13 8 
     
Ruptured 128 82 26 18 
Unruptured   108 80 19 11 
Overall (%) 236 162(68.6) 45(19.1) 29(12.3) 
Table 2. Immediate angiographic occlusion classification 
Aneurysm occlusion rate was analyzed in relation to different stenting techniques, bail-out 
stenting cases excluded. Stenting before coiling was performed in 205 aneurysms and 
angiographic results showed class 1 occlusion in 142 (69.3%) aneurysms, class 2 in 39 
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(19.0%) aneurysms, and class 3 in 24 (11.7%) aneurysms. Stenting after balloon-assisted 
coiling was performed in 24 aneurysms and angiographic results showed class 1 occlusion 
in 19 (79.2%) aneurysms, class 2 in 3 (12.5%) aneurysms, and class 3 in 2 (8.3%) aneurysms. 
On comparative analysis of stenting before coiling versus stenting after balloon-assisted 
coiling, the complete occlusion rate did not show statistical difference ( P=0.315, Χ2 test ). 
3.2. Procedure-related complications 
Of the total of 239 procedures for 232 patients, 34 procedural complications occurred, of 
which 26 were in the anterior circulation and 8 in the posterior circulation. Table 3 
summarizes the procedural complications. Procedure-related morbidity and mortality were 
4.2% and 1.3%, respectively. 
Complication No sequela Morbidity Mortality Total Incidence(%) 
Thomboembolism 8 4 1 13 5.4 
Intraprocedural rupture 3 3 2 8 3.3 
Coil protrusion 5 0 0 5 2.1 
New mass effect 1 2 0 3 1.3 
Vessel injury 2 1 0 3 1.3 
Stent dislodgement 2 0 0 2 0.8 
Total 21 10 3 34 14.2 
Note: Results include patients with more than one complication. 
Table 3. Procedure-related complications in aneurysms 
3.2.1. Thomboembolism 
Thirteen periprocedual thromboembolic events occurred; 9 were in ruptured aneurysms and 
4 in unruptured ones. Nine thromboembolic complications were evident during the 
procedure, and four were clinically and angiographically noted after the procedure. Com-
plete or partial recanalization was achieved in 9 cases by local or systemic administration of 
abciximab or urokinase and mechanical disruption of clot with microwire immediately. On 
last follow-up, eight patients completely recovered, two patients developed residual mild 
neurological deficit and independent daily activity, and two patients developed hemiplegia 
and became dependent. A 68-year-old woman with ruptured PcomA aneurysm (Hunt-Hess 
gradeⅠ) developed right hemiparesis six hours after the procedure. A thrombus in the 
distal stent segment of right ICA was confirmed by angiography and the left cerebral 
hemisphere infarction was noted by MRI. She developed severe brain herniation eventually, 
and decompressive craniotomy failed to save her life.  
3.2.2. Intraprocedural rupture 
Intraprocedural aneurysmal rupture occurred in eight aneurysms due to coil extrusion 
(n=2), microcatheter protrusion (n=5), or inflation of the balloon (n=1): three in the PcomA, 
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two in the ophthalmic artery, one in the AComA, one in the AchoA, and one in the basilar 
tip. All eight ruptures occurred during embolization of acutely ruptured small aneurysms, 
four of which occurred when coiling microcatheter accessed the aneurysm through the 
struts of the stent. All intraprocedural ruptures were managed with a protamine injection 
for heparin reversal and further coil embolization. External ventricular drainage (EVD) 
surgery was preformed in four cases with postprocedural Fisher grades of Ⅲ or Ⅳ. Five of 
these ruptures resulted in adverse outcome (3 neurological sequelae, 2 death). 
3.2.3. Coil protrusion 
Coil protrusion occurred in five procedures, in four of which the last several loops of a small 
coil (diameter 2 mm) in part protruded through the interstice after detachment, and in one 
of which the coil was unraveled when a second stent-assisted coiling was performed on a 
71-year-old female with bilateral PComA aneurysms. During positioning of the third coil (3 
mm × 6 cm), the microcatheter was repelled from the aneurysm from the aneurysm into the 
parent vessel, and it was noted that the trailing end of the coil was unraveled, with several 
loops in the parent vessel, which affected the blood flow. After attempts to pull back the coil 
or to replace the coil failed, a balloon catheter was introduced into the guiding catheter, and 
the trailing end of the coil was caged in the guiding catheter by inflation of the balloon. Then 
the coil was stretched into the aorta. Fortunately, none of these patients had sequela. 
3.2.4. New mass effect 
Cranial nerve III palsy occurred in three large PComA aneurysms, which thought to be the 
result of the compressive effect of a coiled aneurysm. Only one patient recovered under 
steroid therapy. 
3.2.5. Vessel injury 
Vessel injury occurred in three procedures. Two cases of small vessel dissections developed 
during balloon manipulations. Each involved the carotid siphon. Both dissections 
spontaneous healed on angiographic follow-up, with no clinical consequence. One case of 
intracranial hematoma was noted in a 67-year-old woman with a ruptured right PcomA 
aneurysm (Hunt-Hess grade II). She developed conscious disturbance about one hour after 
treatment. Intracranial CT showed 30 ml hematoma in the right ipsilateral fissure, most 
probably due to MCA injury with the microguidewire used for stent introducement. 
Surgical evacuation was performed and she discharged with mild hemiparesis. 
3.2.6. Stent dislodgement 
Stent dislodgement during treatment occurred in two procedures: one caused by aneurysm 
catheterization through the stent struts and the other caused by retrieving the coiling 
catheter jailed between the stent and vessel wall. In the former case, the stent still covered 
the aneurysm neck and embolization was completed successfully. In the latter case, the coil 
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mass partially herniated to the parent artery, which blocked the blood flow, during 
treatment for a left paraclinoid ICA aneurysm. Fortunately, we did not pull back the 
exchange microwire over which the stent delivery system was brought up. Another 
Neuroform stent (4.5 × 30 mm) was advanced through that exchange microwire and 
successfully deployed across the aneurysm neck. The herniated coil mass was pushed back 
against the vessel wall, and complete flow recanalization was achieved, with no clinical 
consequence (Figure 3).  
 
Figure 3. Angiography showed a left paraclinoid ICA aneurysm in a 62-year-female (A). Retrieving the 
coiling catheter jailed between the stent and vessel wall caused Enterprise stent dislodgement and the 
coil mass partially herniated to the parent artery, which blocked the blood flow (B). A Neuroform stent 
(4.5 × 30 mm) was advanced through the exchange microwire and successfully deployed across the 
aneurysm neck to push back the coil mass against the vessel wall (C). Frontal and lateral angiogram (D 
E) showed complete flow recanalization of the parent artery and class2 occlusion of the aneurysm. 
3.3. Nonprocedural complications attributable to SAH 
3.3.1. Vasospasm 
Though all 129 patients with SAH were managed with systemic administration of 
Nimodipine and/or lumbar drainage of cerebrospinal fluid, twenty-four (18.6%) had 
systematic vasospasm, resulting in five cases of parent artery occlusion during the 
procedure. one aneurysm was located at AComA, Two at PcomA, and two at basilar tip. 
They were managed with local administration of Nimodipine 3mg and narceine 30mg 
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immediately. Three patients resolved well after administration and had no deficit. In a 58-
year-old woman with ruptured basilar tip aneurysm (Hunt-Hess grade Ⅲ), after a 
successful stent deployment vasospasm was noted in the basilar trunk. After immediate 
management, angiogram showed vasospasm completely resolved. However, she did not 
recover from the transient ischemia. Fellow-up MR showed infarct in the pons. Eventually, 
she discharged to a skilled nursing facility, not cognitively able to participate in her care. In 
a 70-year-old man with ruptured left paraclinoid ICA aneurysm (Hunt-Hess grade Ⅲ), 
vasospasm was noted in the left supraclinoid ICA during post-procedure angiography. 
After immediate management, angiogram showed vasospasm completely resolved. 
However, decreased level of consciousness occurred 24 hours later after the treatment. CT 
scan showed left cerebral hemisphere infarction. Cerebral angiography revealed diffuse 
severe bilateral anterior and posterior circulation vasospasm. An emergent decompressive 
craniotomy was performed. This patient had a long recovery with right hemiplegia and 
expressive aphasia, and then discharged to a skilled nursing facility. 
3.3.2. Hydrocephalus 
Of the 129 patients with SAH, nine (6.9%) had shunt-dependent hydrocephalus. All these 
nine patents received EVD only. One poor-grade patient died of the initial effect of SAH, 
and other patients recovered gradually. no patients developed chronic hydrocephalus at 
clinical follow-up. 
3.4. Clinical outcome 
Three patients died of procedure-related complications, and eight patients with acute SAH 
(high Hunt-Hess grade) died because of the severity of their initial hemorrhage during 
hospitalization. All other 221 patients were clinically evaluated. Clinical follow-up was 
obtained from < 1 month to 81 months with a mean of 57.7 months. The mRS score was 
excellent in 167 patients, good in 38 patients, and poor in 11 patients at last follow-up. Five 
died of other diseases. No rehemorrhage of treated aneurysm occurred. 
3.5. Follow-up complications 
3.5.1. Aneurysm recanalization 
Follow-up angiography was obtained using DSA or MRA in 155 patients with 159 treated 
aneurysms. Angiographic follow-up was obtained from 3 to 62 months, with a mean of 39.2 
months. 131 of the 155 patients (84.5 %) had >1 year follow-up. The main reasons that 
patients were lost to follow-up were the patients’ refusal to return, economical problem and 
travel distance. In these 159 angiographic followed aneurysms, the follow-up angiograms of 
23 aneurysms (14.5 % of the follow-up angiograms) demonstrated recanalization (Table 4). 
Of note, 8/22 (36.4 %) class 2 and class 3 aneurysms converted to class 1 on last follow-up. 
Seventeen of these aneurysms underwent successful re-embolization. The other six patients’ 
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angiogram showed an increasing remnant neck on the first follow-up examination, but the 
subsequent follow-up angiogram showed a stable appearance. Therefore, re-embolization 
was not a treatment option for them. No symptomatic procedural complications were seen 
in the retreatment. 
Aneurysm size Recanalized 
Small 9/102 
Large             6/31 
Giant 8/26 
Overall 23/159(14.5) 
  
Immediate aneurysm result Recanalized (%) 
Class 1 9 /108 
Class 2 9/32 
Class 3 5 /19 
Overall 23/159 (14.5) 
Table 4. Recanalization rates 
3.5.2. Chronic effect on parent artery  
In-stent stenosis was confirmed in two patients by follow-up angiography. In a 45-year-old 
man, after stent-assisted coiling of a VB aneurysm, delayed in-stent stenosis was seen at 3-
month follow-up but had resolved spontaneously at 12-month follow-up. Fortunately, he 
patient had no symptom. In a 65-year-old man, a 4.5 mm ×15 mm Neuroform stent was 
deployed in the paraclinoid and communicating segments of right ICA to treat a PcomA 
aneurysm. High-grade stenosis within the stented segments of right ICA was present 13 
months after the procedure. He suffered from a mild left hemiparesis. In view of the severity 
of the stenosis and symptoms while on aspirin, balloon angioplasty of the right ICA was 
performed. Postangioplasty control angiography demonstrated substantial improvement in 
the caliber and the patient recovered fully (Figure 1).  
One patient developed ophthalmic artery occlusion 6 months after the procedure in whom 
the ophthalmic artery origin was bridged with the stent. Fortunately no clinical problem 
occurred because of the reconstruction of the ophthalmic artery via external carotid artery 
collaterals. 
A case of Déjérine syndrome occurred in a 52-year-old woman with a VB junction aneurysm 
treated by stent-assisted coiling eight month after the procedure. She suffered from vertigo, 
bilateral deep sensory disturbance and right mild hemiparasis. Diffusion-weighted MRI 
demonstrated increased signal in the medial medulla. The mechanism was suggested that 
unusually aggressive neointimal response to the stent resulted in occlusion of a small 
penetrating artery from the stented segment of the vertebral artery, though direct evidence 
was not found by angiography. (Figure 4) 
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Figure 4. Frontal and lateral angiogram (A B) showed VB junction aneurysm in a 52-year-old woman. 
Complete occlusion was achieved by stent-assisted coiling (Neuroform 4.5mm ×30mm) (C). Diffusion-
weighted MRI demonstrated increased signal in the medial medulla eight month after the procedure 
(D). Fowllow-up angiogram demonstrated that the stented segment of the parent artery appeared 
intact, with no evidence of dissection or in-stent stenosis (E F). 
3.5.3. Hemorrhagic events 
No rehemorrhage of treated aneurysm occurred. One 73-year-old male died of contralateral 
putaminal hemorrhage 7 months after discharge. Though he had a history of hypertension 
for nearly 20 years, posttreatment antiplatelet might be a precipitating factor.  
3.6. Incidences of thromboembolism and intraprocedural rupture in ruptured vs 
unruptured aneurysms 
All 8 intraprocedual ruptures, and 9 of 13 thromboembolic events were in the SAH group. 
The incidence of intraprocedural rupture and thromboembolism were 6.2% and 6.9%, 
respectively, in the ruptured group and 0% and 3.6%, respectively, in the unruptured group. 
There was a statistically significant difference in the incidence of intraprocedural rupture 
between two groups (P =0.008). The incidence comparison for thromboembolism between 
these groups, however, gave a P value of 0.256. 
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4. Discussion 
Endovascular and surgical treatment of wide-neck and fusiform intracranial aneurysms 
has remained technically challenging. Stent-assisted aneurysm embolization is a new tool 
in the treatment of intracranial aneurysms and maybe particularly useful in the case of 
wide-necked or dissecting aneurysm. The earliest clinical report of stent-assisted coiling 
of an intracranial ruptured cerebral aneurysm is by Higashida et al, in 19972. From then 
on, with improvements in microstent technology, more reports from various centers 
describing the experimental and clinical use of different stents for embolization assistance 
has reported good results in the literature.7-13 Up till now, several literatures have 
demonstrated the technical feasibility, efficacy of treating complicated intracranial 
aneurysms. 14-17 The stent can provide a permanent scaffold across the aneurysm neck, 
which may prevent coil prolapse into the parent artery and allow for safer packing of the 
aneurysm with a denser coil mesh. In addition, the stent may help prevent recanalization 
by hemodynamic changes and stent endothelialization. 17However, as a new device, there 
is limited knowledge about the complications and the long-term effects of the stent on the 
cerebrovasculature. 
We have found that the overall procedure-related complication, morbidity and mortality 
were 14.2 %, 4.2 % and 1.3 %, respectively, and that a cumulative excellent or good clinical 
outcome rate is 88.3 %, which reflect better outcome than open surgical series. Most of our 
complication cases were treated during the first half of our experience period. 
4.1. Ischemic events 
Ischemic event is a significant problem in periprocedural period. Usually, thromboembolism 
is the main cause of ischemic event. 18 Park observed nine thromboembolic events among 27 
complications during coiling of 118 ruptured aneurysms.19 The acute or subacute 
thrombogenicity of endovascular stents also represents an important limitation with respect 
to the treatment of aneurysms and appears to be the main drawback of stent-assisted coil 
embolization. 20-24 According to these literatures, incidence of thromboembolic event ranged 
from 4.2 to 17.1%. In our series, we observed a relatively low rate of thromboembolic events 
(5.4%), with 1.6% morbidity and 0.4% mortality. Our findings suggest stent-assisted coiling 
does not increase the risk of thromboemblism with proper management, which is similar to 
those of some reports. 18This low rate of thromboembolic events has been achieved with 
enough heparinisation, dual pre- and postoperative antiplatelet therapy, shorten duration of 
endovascular manipulation, and sufficient prevention from injection of embolus into 
circulation. Additionally, the use of bioactive coils (e.g. Matrix coil) in conjunction with the 
stent should be avoided. Partially thrombosed aneurysms can be coiled using the balloon 
remodeling technique, and then the stent is delivered across the aneurysm neck at the end of 
the procedure. Once thromboembolism is noted, local intra-artery administration of 
abciximab or urokinase and mechanical disruption of clot with microwire are necessary. 
Sometimes mechanical dilation with balloon angioplasty can be performed. 
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Delayed in-stent stenosis is likely a rare event. Biondi et al 16 reported one (2.4%) 
asymptomatic stenosis of the parent artery at the proximal end of the stent, which was 
observed on follow-up angiography and successfully treated by angioplasty. Fiorella et al 25 
reported a 5.8% rate (9 of 156 patients) of delayed moderate to severe (>50%) in-stent 
stenosis after 2 to 9 months, of which two patients needed retreatments to control ischemic 
symptoms. In our series, in-stent stenosis was confirmed in two patients, one of whom 
underwent angioplasty. The Wingspan study26, reported a rate of in-stent stenosis of 29.7% 
and an additionally 4.8% of in-stent thrombosis after an average of 5.9 months on the 
treatment for symptomatic intracranial atheromatous disease. Endothelian disruption and 
denudation of the vascular wall during stenting in the absence of functional endothelium in 
an atheromatous vessel resulting in neointimal tissue formation may play an important role. 
This action is mediated by proliferation and activation of regional smooth muscle cells. It is 
unclear whether similar reaction is also responsible for delayed in-stent stenosis after the 
stent placement, which has much lower radial force, as an aneurysm neck bridging device 
covering the normal vessel wall. Additional follow-up will be critical to delineate the 
incidence of this phenomenon. 
Delayed ischemic neurological deficit associated with vasospasm is a major cause of 
morbidity and mortality in patients with SAH. Symptomatic vasospasm is reported in 22–
40% of patients with SAH, resulting in 34% morbidity and 30% mortality rates. 27-31 
Murayama et al 32 reported a 23% incidence of symptomatic vasospasm after endovascular 
coil occlusion of acutely ruptured; this rate compares favorably with that found in 
conventional surgical series. Gruber et al33, however, noted an increased incidence of 
vasospasm-related infarctions in patients treated endovascularly (37.7% vs. 21.6% with 
surgery). However, when patients with Fisher grade 4 and Hunt and Hess grade V lesions 
were excluded, the difference between the treatment groups was no longer significant. 
Other authors 19,34,35 have not found an increased risk of vasospasm with endovascular 
therapy as well. They concluded that the type of treatment was not associated with an 
increased risk of cerebral vasospasm. Rabinstein et al 36 studied 415 consecutive patients 
with aneurysmal SAH. Symptomatic vasospasm occurred in 39% treated with surgical clip 
placement and 30% treated with endovascular coil occlusion. In a univariate analysis, the 
incidence of vasospasm did not differ between the groups. In our study, the incidence of 
symptomatic vasospasm among 129 patients with SAH was 18.6%. It seems that the stent-
assisted coiling does not increase the risk of symptomatic vasospasm, compared with open 
clipping and other endovascular techniques. 
4.2. Stenting techniques 
Different stategies regarding the timing of stent deployment in relation to coiling are 
practiced. In majority of reports, stenting was performed before coiling in the same session, 
including the sequential technique and the jailing technique.9, 20-22 The strategy of stenting 
after balloon-assisted coiling is less frequently reported. 21, 16 In our series, several main 
options were practiced and the strategy of stenting before coiling was predominantly used. 
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On comparative analysis of stenting before coiling versus stenting after balloon-assisted 
coiling, the complete occlusion rate did not show significant difference ( P>0.05, Χ2 test ). 
However, balloon remodeling technique have some drawbacks according to our experience 
(maybe bias). Coil mass herniation is sometimes a limitation of balloon-assisted coiling once 
the balloon is deflated or removed. Repeated inflation and deflation of the balloon may 
cause intimal damage37, which has occurred in our series. Furthermore, balloon inflation, 
which results in complete blood flow arrest in the parent artery, can increases the risk of 
thromboembolic events38, 39, although this is still controversial. In our series, a novel stent-
assisted coiling technique, the semi-deployment technique, was used in 31 aneurysms. 
Compared to the conventional techniques, this technique has several advantages. First, it 
increases maneuverability of the coiling catheter, allowing more controlled coil positioning. 
Second, the coil basket can be optimized and there is less likelihood for coil migration when 
the aneurysm neck is narrowed by the partially deployed stent. Last, it decreases the risk of 
the stent herniating into the aneurysm in treatment of large or giant aneurysm. 
Nevertheless, further experience is necessary to determine complication rate and suitable 
selection of patients to different strategies. 
4.3. Dual antiplatelet regimen 
There are controversial reports about benefit of the dual antiplatelet therapy. 40, 41 The 
optimal regimen has not yet been defined. It is intuitive that the aneurysms are fragile and 
parent vessels are less healthy in patients in the acute phase of SAH. A meta-analysis of 
published reports, from retrospective data has also suggested the risk of intraprocedure 
rupture is significantly higher in patients with ruptured aneurysms. Our data suggest that 
the incidence of intraprocedual rupture is significantly higher in patients with ruptured 
aneurysm (P<0.01), and the incidence of thromboembolism between those with and without 
ruptured aneurysms is not statistically significant. This finding may advocate for a more 
cautious preprocedural antiplatelet treatment for patients with ruptured aneurysms. 
Katsaridis V has reported a very low thromboembolic complication rate (1.8%) in the 
Neuroform2 stent-assisted embolization of 54 aneurysms without antiplatelet 
pretreatment.40 In our practice, it is after general anesthesia that dual antiplatelet treatment 
(aspirin 300 mg and clopidogrel 225 mg via nasogastric tube) initiates for accurately 
ruptured aneurysms.  
Because of a prolonged posttreatment antiplatelet regimen, if there is any evidence that the 
patient will need EVD surgery due to SAH, this should be done before interventional 
therapy. On the basis of our experience, this might not only prevent fatal increase of 
intracranial pressure, but might also reduce subsequent bleeding complications if the patient 
is on a strong anticoagulation and antiplatelet regimen. However, in our series, a total of 
seven patients underwent additional emergent surgical treatment after interventional 
therapy. Five patients received EVD and two patients underwent decompressive 
craniotomy. Protamine chloride and minirin were used to reverse the anticoagulation and 
antiplatelet drugs before surgery. Fortunately, there were no surgical complications or 
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special difficulties due to abnormal intraoperative bleeding during the operation. Taking 
into account relatively more ischemic events, a more aggressive anticoagulation and 
antiplatelet therapy should be used after the procedure.  
In our opinion, the risk of periprocedual antiplatelet therapy should be weighed against the 
potential benefit and that antiplatelet and anticoagulation therapy should be tailored 
according to the results of ongoing researches. 
4.4. Aneurysm recanalization 
The goal of aneurysm treatment should be permanent exclusion of the aneurysm from the 
circulatory system to prevent rupture or rerupture. Aneurysm recanalization must be 
acknowledged as a failure to achieve this goal. However, not a single one of treated 
aneurysms experienced rehemorrhage during the follow-up time, in our series, despite 
incomplete occlusion and recanalization. Lylyk et al reported that follow-up was obtained in 
63% of their patients and stressed that there were no cases of repeated hemorrhage.21 Biondi 
et al 16 also reported that no aneurysm bled after stent-assisted coiling during the follow-up 
period, though complete or subtotal aneurysm occlusion was not always obtained. Based on 
these results, we therefore conclude that the risk of rupture after occlusion of aneurysms 
may be substantially reduced. Aneurysm follow-up angiography and reembolization, if 
necessary, still should be done, though. Fiorella et al 22 reported initial (3-6 mo) angiographic 
follow-up in 58% of aneurysms treated with Stent-assisted coiling showing progressive 
thrombosis in 52% of patients, recanalization in 23%, and no change in 25%. In the series of 
Biondi et al 16, recanalization was observed in 13% of wide-neck aneurysms treated with 
stent-assisted coiling. We observed 23 cases (14.5%) of aneurysm recanalization on follow-
up angiograms, which was acceptable compared with most publications. In our experience, 
the recanalization rate of none-stented wide-neck aneurysms is high. Murayama et al 
reported that the overall recanalization rate of coiling without stenting was 20.9%.6 A stent 
placed across the aneurysm neck may prevent recanalization because of the hemodynamic 
changes and stent endothelialization. The stent is used not only to assist in coil delivery, but 
also to prevent recanalization. In our series 60.9% (14/23) of the recanalized aneurysms were 
not initially completely occluded (class2 or class3) and no recanalization occurred in small 
aneurysms which was completely occluded. Therefore, sequential follow-up angiograms are 
mandatory, especially for those aneurysms showing incomplete occlusion. In our series, no 
adverse events were shown on follow-up angiograms or occurred during retreatment with 
detachable coils. Recently, Renowden et al 42 and Henkes et al 43 reported complication rates 
of 2% to 3% in their large series of retreatment of previously embolized aneurysms. Follow-
up procedures can be done safely, and the risk from retreatment with detachable coils does 
not negate the advantages of initial use of coil embolization. During initial treatment 
discussions, patients should aware that wide-neck aneurysms, especially large and giant 
ones, may require multiple treatment and will certainly require a significant course of long-
term follow-up. 
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5. Conclusion 
Our study indicates that stent-assisted coil embolization of intracranial aneurysm is a safe 
technique with low morbidity and mortality rates. Our results are consistent with those 
reported in the literature (Table 5). The main cause of morbidity and mortality is 
thromboembolism (38.2% of all procedure-related complications are thromboembolic in 
our study). In our hand, this technique does not increase the risk of symptomatic 
vasospasm, compared with open clipping and other endovascular techniques. The 
recanalization rate is relatively low. The delayed in-stent stenosis seems a rare 
complication, compared to stent deployment in atherosclerotic lesions. Nevertheless, 
additional, large series with long-term follow-up are necessary to determine the durability 
of these promising results. 
 
Series (ref no) 
No of 
patients 
(aneurysms)
Rate 
Fiorella et al. 2004 (15) 19 (22) 10.5% thromboembolism rate (10.5% thromboembolic 
morbidity) 
dos Santos et al. 2005(17) 18 (17) 23.5% technical complication rate (5.8% morbidity) 
Lee et al. 2005(23) 22 (23) 9.1% procedure-related complication rate 
Akpek et al. 2005(20) 32 (35) 25% adverse event rate, 9.3% morbidity, 3.1% mortality 
Lylyk et al. 2005(21) 50 (50) 8.6% morbidity, 2.1% mortality 
Katsaridis et al. 2006(38) 44 (54) 4% stent-related complication rate 
Biondi et al. 2007(16) 42 (46) 4.3% procedural morbidity, 2.2% procedural mortality 
Yahia et al. 2008 (3) 67(67) 7.4% procedure-related complication rate 
Mordasini et al. 2008 (44) 18(18) 22.2% thromboembolism rate( no morbidity and 
mortality) 
Wajnberg et al. 2009 (24) 24 (24) 4.2% procedure-related thromboembolism rate 
Seadt J et al. 2009 (45) 42(42) 2.4% procedural morbidity 
Table 5. Published complication rates for Neuroform stent-assisted coiling of intracranial aneurysms 
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